Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
We prioritize speed and delivery to ensure your projects stay on track
Published research on dual-modified short peptides has documented an average improvement in half-life of approximately 9.5-fold over unmodified sequences in simulated biological fluid (1)
Its role as a key coenzyme in redox reactions makes it a subject of significant interest in cellular biology and metabolic pathway research
It does not require proof of efficacy in large trials the way we typically expect from drugs, but it facilitates prescribing, and that changes things a lot, because there wont be a black market anymore
BPC-157 is not FDA-approved for human use
